What Happened?
South San Francisco, CA-based Portola Appointed Ravi Kumar Monangi as Senior Director, IT
Date of management change: August 23, 2019
South San Francisco, CA-based Portola Appointed Ravi Kumar Monangi as Senior Director, IT
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Ravi Kumar Monangi is Senior Director, IT at Portola. Previously, Ravi held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Voje Joe, Doster Jeffrey, Venkataraman Ram, Summers Kristen, Rodriguez Christopher, Simons Preston, Doyle Robert, Matz Laura, Kerst Udo, Kane Latonick Hahna, Friedman Jay
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.